A detailed history of Rather & Kittrell, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Rather & Kittrell, Inc. holds 1,315 shares of LLY stock, worth $1.06 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
1,315
Holding current value
$1.06 Million
% of portfolio
0.26%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$725.72 - $929.72 $954,321 - $1.22 Million
1,315 New
1,315 $1.09 Million
Q1 2022

May 10, 2022

SELL
$234.69 - $291.66 $44,825 - $55,707
-191 Closed
0 $0
Q4 2021

Feb 18, 2022

BUY
$224.85 - $279.04 $42,946 - $53,296
191 New
191 $52,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $767B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Rather & Kittrell, Inc. Portfolio

Follow Rather & Kittrell, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rather & Kittrell, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Rather & Kittrell, Inc. with notifications on news.